42 research outputs found

    Ground state properties of a one-dimensional condensate of hard core bosons in a harmonic trap

    Full text link
    The exact N-particle ground state wave function for a one-dimensional condensate of hard core bosons in a harmonic trap is employed to obtain accurate numerical results for the one-particle density matrix, occupation number distribution of the natural orbitals, and momentum distribution. Our results show that the occupation of the lowest orbital varies as N^{0.59}, in contrast to N^{0.5} for a spatially uniform system, and N for a true BEC.Comment: 10 pages, 6 figures, submitted to Phys. Rev.

    Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia

    Get PDF
    Hypercholesterolemic patients (n = 1,547) at high atherosclerotic cardiovascular disease risk with low-density lipoprotein cholesterol (LDL-C) levels 65100 and 64160 mg/dl while treated with atorvastatin 10 mg/day entered a multicenter, randomized, double-blind, active-controlled, clinical trial using two 6-week study periods. Period I compared the efficacy/safety of (1) adding ezetimibe 10 mg (ezetimibe) to stable atorvastatin 10 mg, (2) doubling atorvastatin to 20 mg, or (3) switching to rosuvastatin 10 mg. Subjects in the latter 2 groups who persisted with elevated LDL-C levels ( 65100 and 64160 mg/dl) after period I, entered period II; subjects on atorvastatin 20 mg had ezetimibe added to their atorvastatin 20 mg, or uptitrated their atorvastatin to 40 mg; subjects on rosuvastatin 10 mg switched to atorvastatin 20 mg plus ezetimibe or uptitrated their rosuvastatin to 20 mg. Some subjects on atorvastatin 10 mg plus ezetimibe continued the same treatment into period II. At the end of period I, ezetimibe plus atorvastatin 10 mg reduced LDL-C significantly more than atorvastatin 20 mg or rosuvastatin 10 mg (22.2% vs 9.5% or 13.0%, respectively, p <0.001). At the end of period II, ezetimibe plus atorvastatin 20 mg reduced LDL-C significantly more than atorvastatin 40 mg (17.4% vs 6.9%, p <0.001); switching from rosuvastatin 10 mg to ezetimibe plus atorvastatin 20 mg reduced LDL-C significantly more than uptitrating to rosuvastatin 20 mg (17.1% vs 7.5%, p <0.001). Relative to comparative treatments, ezetimibe added to atorvastatin 10 mg (period I) or atorvastatin 20 mg (period II) produced significantly greater percent attainment of LDL-C targets <100 or <70 mg/dl, and significantly greater percent reductions in total cholesterol, non-high-density lipoprotein cholesterol, most lipid and lipoprotein ratios, and apolipoprotein B (except ezetimibe plus atorvastatin 20 vs atorvastatin 40 mg). Reports of adverse experiences were generally similar among groups. In conclusion, treatment of hypercholesterolemic subjects at high cardiovascular risk with ezetimibe added to atorvastatin 10 or 20 mg produced significantly greater improvements in key lipid parameters and significantly greater attainment of LDL-C treatment targets than doubling atorvastatin or switching to (or doubling) rosuvastatin at the compared doses

    Short Prolegomena of a »Right to a Home« in the Consumer Bankruptcy Act

    Get PDF
    Kriza identiteta modela »socijalne države« otvorila je niz pitanja za teoretičare i praktičare. Ovi problemi, naravno, nisu zaobišli niti sustav potrošačko stečajne zaštite kojoj je primarni cilj ekonomska i socijalna »rehabilitacija« potrošača što je differentia specifica u odnosu na primarni cilj korporativnog stečaja, namirenje vjerovnika. Prostor koji ovdje imamo ne dopušta detaljnu raščlambu ove problematike, pa smo prinuđeni ograničiti se isključivo na jedno od ključnih pitanja novog potrošačko stečajnog zakonodavstva: prava na dom. Pritom se posebno analizira praksa Europskog suda za ljudska prava (dalje: Europski sud) u postupcima prema čl. 8. Europske konvencije za zaštitu ljudskih prava i temeljnih sloboda (»Pravo na dom«) jer polazimo od pretpostavke da saznanja o ovome mogu biti ključna za razumijevanje problematike rada, kao i za pravilnu primjenu instituta prava na dom. U cilju što sveobuhvatnijeg odgovora na samu temu, uz uvažavanje prethodno navedenog, struktura i koncept rada je tome morao biti prilagođen. Ovaj rad mogao je biti podijeljen na tri dijela što će se i vidjeti tijekom njegovog čitanja, ali to formalno nije učinjeno.The identity crisis of a »welfare state» model has raised a number of questions for theorists and practitioners. These problems, of course, have not surpassed the system of consumer bankruptcy protection which has the primary objective - economic and social »rehabilitation« of consumers and which is differentia specifica in relation to the primary objective of corporate bankruptcy − settlement of creditors. The scope of this paper does not permit a detailed analysis of these issues, and we are forced to limit ourselves exclusively to one of the key issues of the new consumer bankruptcy law: the right to a home. We specifically analyze the practice of the European Court of Human Rights (hereinafter: European Court) in proceedings under Art. 8 of the European Convention for the Protection of Human Rights and Fundamental Freedoms ("Right to a Home") because we assume that it is a key to understanding the paper subject, as well as to the proper application of the institute of “right to a home”. With respect to the foregoing, in order to have a comprehensive answer to the subject, the structure and concept of paper had to be adjusted. This paper could have been divided into three parts, but it has not been formally done
    corecore